Bausch & Lomb eye care products on display at Maximart Pharmacy in Palo Alto, Calif., on May 16, 2007. Valeant Pharmaceuticals Inc. has confirmed it's buying Bausch + Lomb Holdings in a US$8.7-billion cash deal that will boost the Canadian drug maker's presence in the eye-care sector.  THE CANADIAN PRESS/AP, Paul Sakuma